Cargando…

Plerixafor as a preemptive or salvage therapy for healthy donors with poor mobilization of hematopoietic stem cells

Detalles Bibliográficos
Autores principales: Kuang, Pu, Lin, Ting, Chen, Xinchuan, Yang, Yunfan, Ji, Jie, Dong, Tian, Wang, Jie, Li, Yan, Niu, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630128/
https://www.ncbi.nlm.nih.gov/pubmed/36076012
http://dx.doi.org/10.1038/s41409-022-01789-1
_version_ 1784823533882310656
author Kuang, Pu
Lin, Ting
Chen, Xinchuan
Yang, Yunfan
Ji, Jie
Dong, Tian
Wang, Jie
Li, Yan
Niu, Ting
author_facet Kuang, Pu
Lin, Ting
Chen, Xinchuan
Yang, Yunfan
Ji, Jie
Dong, Tian
Wang, Jie
Li, Yan
Niu, Ting
author_sort Kuang, Pu
collection PubMed
description
format Online
Article
Text
id pubmed-9630128
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96301282022-11-04 Plerixafor as a preemptive or salvage therapy for healthy donors with poor mobilization of hematopoietic stem cells Kuang, Pu Lin, Ting Chen, Xinchuan Yang, Yunfan Ji, Jie Dong, Tian Wang, Jie Li, Yan Niu, Ting Bone Marrow Transplant Correspondence Nature Publishing Group UK 2022-09-08 2022 /pmc/articles/PMC9630128/ /pubmed/36076012 http://dx.doi.org/10.1038/s41409-022-01789-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Kuang, Pu
Lin, Ting
Chen, Xinchuan
Yang, Yunfan
Ji, Jie
Dong, Tian
Wang, Jie
Li, Yan
Niu, Ting
Plerixafor as a preemptive or salvage therapy for healthy donors with poor mobilization of hematopoietic stem cells
title Plerixafor as a preemptive or salvage therapy for healthy donors with poor mobilization of hematopoietic stem cells
title_full Plerixafor as a preemptive or salvage therapy for healthy donors with poor mobilization of hematopoietic stem cells
title_fullStr Plerixafor as a preemptive or salvage therapy for healthy donors with poor mobilization of hematopoietic stem cells
title_full_unstemmed Plerixafor as a preemptive or salvage therapy for healthy donors with poor mobilization of hematopoietic stem cells
title_short Plerixafor as a preemptive or salvage therapy for healthy donors with poor mobilization of hematopoietic stem cells
title_sort plerixafor as a preemptive or salvage therapy for healthy donors with poor mobilization of hematopoietic stem cells
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630128/
https://www.ncbi.nlm.nih.gov/pubmed/36076012
http://dx.doi.org/10.1038/s41409-022-01789-1
work_keys_str_mv AT kuangpu plerixaforasapreemptiveorsalvagetherapyforhealthydonorswithpoormobilizationofhematopoieticstemcells
AT linting plerixaforasapreemptiveorsalvagetherapyforhealthydonorswithpoormobilizationofhematopoieticstemcells
AT chenxinchuan plerixaforasapreemptiveorsalvagetherapyforhealthydonorswithpoormobilizationofhematopoieticstemcells
AT yangyunfan plerixaforasapreemptiveorsalvagetherapyforhealthydonorswithpoormobilizationofhematopoieticstemcells
AT jijie plerixaforasapreemptiveorsalvagetherapyforhealthydonorswithpoormobilizationofhematopoieticstemcells
AT dongtian plerixaforasapreemptiveorsalvagetherapyforhealthydonorswithpoormobilizationofhematopoieticstemcells
AT wangjie plerixaforasapreemptiveorsalvagetherapyforhealthydonorswithpoormobilizationofhematopoieticstemcells
AT liyan plerixaforasapreemptiveorsalvagetherapyforhealthydonorswithpoormobilizationofhematopoieticstemcells
AT niuting plerixaforasapreemptiveorsalvagetherapyforhealthydonorswithpoormobilizationofhematopoieticstemcells